Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunitybio Inc (NQ: IBRX ) 4.010 +0.030 (+0.75%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Immunitybio Inc < Previous 1 2 3 4 5 6 Next > Top 3 Health Care Stocks That Are Set To Fly This Quarter August 16, 2024 Via Benzinga 9 Health Care Stocks Whale Activity In Today's Session August 13, 2024 Via Benzinga IBRX Stock Earnings: ImmunityBio Misses EPS, Misses Revenue for Q2 2024 August 12, 2024 IBRX stock results show that ImmunityBio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace 7 Biotech Stocks to Keep on Your Clinical Radar July 23, 2024 Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs. Via InvestorPlace 3 Top Cancer Treatment Stocks to Buy Now July 17, 2024 These cancer treatment stocks are well-positioned to benefit tremendously from strong demand for their cancer treatments in the longer term. Via InvestorPlace How Is The Market Feeling About ImmunityBio? May 17, 2024 Via Benzinga Check Out What Whales Are Doing With IBRX April 30, 2024 Via Benzinga China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio? June 23, 2024 Top performing mid-cap stocks last week: BILI (+23%), IBRX (+22%), SSL (+20%), OLLI (+15%), ITCI (+13%), AMKR (+12%), IRTC (+11%), RKLB (+11%), BFH (+10%), BRFS (+10%). Via Benzinga Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga Why ImmunityBio Stock Is Trading Higher Thursday June 20, 2024 The company announced insurance coverage of ANKTIVA, a immunotherapy used to treat non-muscle invasive bladder cancer that was unresponsive to other specific treatments. Via Benzinga KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday June 20, 2024 Via Benzinga 3 Short-Squeeze Stocks Outwitting the Pessimistic Predictions June 20, 2024 Don't be discouraged by the bears. Here are my three picks of short-squeeze stocks to buy for investors everywhere. Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session June 11, 2024 Via Benzinga These 3 Interesting Stocks Are Seeing Heavy Short Interest In June 2024 June 04, 2024 Economic slowdown meets short-selling speculations. Candidates for incoming market volatility are here. Via Talk Markets Amid Biotech Pitfalls, ImmunityBio Has Outperformed NVDA In The Last 3 Months May 13, 2024 In the last three months, IBRX outperformed NVDA by over 3x. Via Talk Markets IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q1 2024 May 10, 2024 IBRX stock results show that ImmunityBio missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace The 3 Best Bargain Stocks to Buy in May 2024 May 09, 2024 There are several types of bargain stocks for investors to consider. Here are the three best bargain stocks to buy now. Via InvestorPlace Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday May 07, 2024 Via Benzinga Even Worse than Gamestop? 3 Meme Stocks That Are Screaming Sells May 06, 2024 Here are just a few of the top meme stocks to sell immediately. In fact, I wouldn't waste investment dollars on any. Via InvestorPlace Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy May 03, 2024 Unlocking global access to Bacillus Calmette-Guerin (BCG) for cancer therapy. ImmunityBio partners with Serum Institute to expand BCG supply. FDA-approved Anktiva plus BCG for bladder cancer. Via Benzinga Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday May 03, 2024 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session May 02, 2024 Via Benzinga Stocks Quietly Climb Ahead Of Central Bank Storm April 29, 2024 The Dow Jones Industrial Average, Nasdaq Composite, and S&P 500 Index are all sporting comfortable leads this afternoon. Via Talk Markets Topics Economy Stocks Exposures Interest Rates US Equities Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 29, 2024 Via Benzinga Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday April 29, 2024 Via Benzinga Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket April 29, 2024 Via Benzinga What's Going On With ImmunityBio Stock? April 26, 2024 ImmunityBio said the QUILT 3.055 trial shows median overall survival almost double that of standard of care chemotherapy in 2nd- and 3rd-line non-small cell lung cancer (NSCLC) patients whose cancer... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session April 26, 2024 Via Benzinga Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket April 25, 2024 Via Benzinga FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies April 23, 2024 FDA approves ImmunityBio's Anktiva plus Bacillus Calmette-Guérin for BCG-unresponsive non-muscle invasive bladder cancer. Anktiva shows promising complete response rates and duration exceeding 24... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.